ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Zip Co Limited

Zip Co Limited (Z1P)

1.21
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.21
Bid
1.205
Offer
1.21
Volume
0.00
0.00 Day's Range 0.00
1.21 52 Week Range 1.21
Market Cap
Previous Close
1.21
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
1,094,377,251
Dividend Yield
-
PE Ratio
833.33
Earnings Per Share (EPS)
-
Revenue
880.26M
Net Profit
3.66M

About Zip Co Limited

Sector
Uranium-radium-vanadium Ores
Industry
Uranium-radium-vanadium Ores
Website
Headquarters
Sydney, New South Wales, Aus
Founded
-
Zip Co Limited is listed in the Uranium-radium-vanadium Ores sector of the Australian Stock Exchange with ticker Z1P. The last closing price for Zip was AUD1.21. Over the last year, Zip shares have traded in a share price range of AUD 1.21 to AUD 1.21.

Zip currently has 1,094,377,251 shares in issue. The market capitalisation of Zip is AUD1.32 billion. Zip has a price to earnings ratio (PE ratio) of 833.33.

Z1P Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
12001.211.211.2100DE
26001.211.211.2100DE
52001.211.211.2100DE
156001.211.211.2100DE
260-5.29-81.38461538466.514.531.205102496166.38843258DE

Z1P - Frequently Asked Questions (FAQ)

What is the current Zip share price?
The current share price of Zip is AUD 1.21
How many Zip shares are in issue?
Zip has 1,094,377,251 shares in issue
What is the market cap of Zip?
The market capitalisation of Zip is AUD 1.32B
What is the 1 year trading range for Zip share price?
Zip has traded in the range of AUD 1.21 to AUD 1.21 during the past year
What is the PE ratio of Zip?
The price to earnings ratio of Zip is 833.33
What is the cash to sales ratio of Zip?
The cash to sales ratio of Zip is 3.42
What is the reporting currency for Zip?
Zip reports financial results in AUD
What is the latest annual turnover for Zip?
The latest annual turnover of Zip is AUD 880.26M
What is the latest annual profit for Zip?
The latest annual profit of Zip is AUD 3.66M
What is the registered address of Zip?
The registered address for Zip is LEVEL 5, 126 PHILLIP STREET, SYDNEY, NEW SOUTH WALES, 2000
What is the Zip website address?
The website address for Zip is www.zip.co
Which industry sector does Zip operate in?
Zip operates in the URANIUM-RADIUM-VANADIUM ORES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
4DXO4DMedical Limited
AUD 0.079
(1,875.00%)
11
GCMOGreen Critical Minerals Ltd
AUD 0.006
(100.00%)
14.75M
SISSimble Solutions Limited
AUD 0.0045
(80.00%)
8.68M
EUROCEuropean Lithium Limited
AUD 0.009
(80.00%)
5.49M
EUROEuropean Lithium Limited
AUD 0.007
(75.00%)
2.57M
ICUInvestor Centre Ltd
AUD 0.001
(-66.67%)
70.75k
PRXProdigy Gold NL
AUD 0.001
(-50.00%)
56.8k
MGAOMetalsGrove Mining Ltd
AUD 0.003
(-50.00%)
79.96k
IMUOEImugene Ltd
AUD 0.001
(-50.00%)
3.63M
GMNGold Mountain Limited
AUD 0.001
(-33.33%)
250.88k
GCMGreen Critical Minerals Ltd
AUD 0.025
(13.64%)
114.43M
LU7OLithium Universe Ltd
AUD 0.001
(0.00%)
59.46M
SGQSt George Mining Ltd
AUD 0.032
(6.67%)
53.13M
LU7Lithium Universe Limited
AUD 0.0095
(58.33%)
41.92M
FAUFirst AU Limited
AUD 0.004
(14.29%)
40.51M

Discussion

View Full Feed
fuagf fuagf 11 minutes ago
As one who agrees yay for them all, as a retired teacher special kudos for the last:

https://scontent-lax3-1.xx.fbcdn.net/v/t39.30808-6/504303855_1035121872140905_2707895258088881484_n.jpg?_nc_cat=104&ccb=1-7&_nc_sid=833d8c&_nc_ohc=9nX-zx1MrM4Q7kNvwH_P3Zn&_nc_oc=Adk-srxeQcezVhzQ5W8cL
Snd101 Snd101 12 minutes ago
If getting this before the eyes of AMRN legal team has 1% chance of making it to the court, I believe the best route would be via one of Amarin employees. If anybody knows an Amarin employee. Stuffs coming from external email hardly gets any attention.
AMRN
sam1933 sam1933 13 minutes ago
Canada has approved the first spot XRP ETF. Purpose Investments received regulatory approval from the Ontario Securities Commission (OSC) to launch the Purpose XRP ETF, which will begin trading on the Toronto Stock Exchange (TSX) under the ticker XRPP on June 18, 2025
XRPUSD
PegnVA PegnVA 15 minutes ago
Anything for attention.
jondoeuk jondoeuk 16 minutes ago
I've heard that an MD Anderson team is developing an off-the-shelf IL-21 armoured CAR-NK cell therapy that will target EGFR and IL13Ra2 https://www.cell.com/cancer-cell/abstract/S1535-6108(24)00272-1

They are also testing another off-the-shelf NK cell therapy with containing deleted o
GILD
fuagf fuagf 18 minutes ago
dbergh, First many immunodeficient people wear masks to protect their lives, that first interviewer is as ignorant as you.

The 2nd again exhibits the ignorance of the one you see as smart:

Type of hormone therapy may determine whether trans men continue to menstruate
Bull_Dolphin Bull_Dolphin 24 minutes ago
Matt Gaetz on involvement with Israel in Iran:

https://worldnews.whatfinger.com/2025/06/17/daaammmn-matt-gaetz-trump-and-iran-israel-hot-take-%f0%9f%94%a5%f0%9f%94%a5/
jttcomm jttcomm 29 minutes ago
Oh boy. You are the wit. So who is this toxic lender you speak of. No offense but it is difficult to believe the stories that go around and around.
NBRI
joeycav11 joeycav11 36 minutes ago
The amount of detail in this new program is extraordinary. You can sense the exuberance of the author.
The main takeaway is that dcvax will be the poster child of this new hugely exciting program.
There isn’t any other exciting drug on the horizon that could get people excited.That’s
NWBO
joeycav11 joeycav11 36 minutes ago
The amount of detail in this new program is extraordinary. You can sense the exuberance of the author.
The main takeaway is that dcvax will be the poster child of this new hugely exciting program.
There isn’t any other exciting drug on the horizon that could get people excited.That’s
NWBO
OzzieTrader OzzieTrader 37 minutes ago
45 million shares traded price 9.2c down 7%
DTREF
JohnKnowsIt JohnKnowsIt 52 minutes ago
Robert Hipple once wrote my opinion letter
WPFH
JohnKnowsIt JohnKnowsIt 53 minutes ago
Pretty incredible Indian river is still on the filings
WPFH
JohnKnowsIt JohnKnowsIt 55 minutes ago
Henry where are my shares? Time for some legal….
WPFH
JohnKnowsIt JohnKnowsIt 56 minutes ago
But no stocks go up in this space… it’s all about selling shares
WPFH
Pickme2 Pickme2 57 minutes ago
Keep adding...at this rate, there will be billions available and you'll be rich..
ATMH
JohnKnowsIt JohnKnowsIt 57 minutes ago
Rich but not a billionaire
WPFH
mdb1 mdb1 59 minutes ago
Futures are UP. I was 100% sure they would be way down tomorrow. What? Who knew.
MP
Pickme2 Pickme2 1 hour ago
Just be patient...you've waited 5 years ...when there was tens of Millions... Now there's hundreds of millions!! Your time will come
ATMH
PickStocks PickStocks 1 hour ago
No one...
COOP
PickStocks PickStocks 1 hour ago
You may claim 41.6.....but who enforces it.....no one...you could be waiting decades thinking JPM owes you something....you may have received it from the GSA.....but the GSA was between WMI, JPM and the FDIC and JPM came away with 600+ million.....escrows were not part of it.....would like for you t
JPM
Jballer134 Jballer134 1 hour ago
BETTER OFF DONATING THE 100$ TO A SOUP KITCHEN
CLNV
jondoeuk jondoeuk 1 hour ago
It will be interesting to see GILD's KITE-753 clinical data. The only difference between it (and KITE-363) is a reduced production time.

However, based on preclinical data, KITE-753 exhibited higher expression of both CARs and increased proportion of CCR7+/CD45RA+ T-cells* compared to
LYEL
jondoeuk jondoeuk 1 hour ago
It will be interesting to see GILD's KITE-753 clinical data. The only difference between it (and KITE-363) is a reduced production time.

However, based on preclinical data, KITE-753 exhibited higher expression of both CARs and increased proportion of CCR7+/CD45RA+ T-cells* compared to
GILD
HyGro HyGro 1 hour ago
Ah, ha, ha. Then why didn't NWBO file with the FDA??? There's no material money in a UK approval. Only the U.S. delivers serious revenue and profitable pricing. If FDA considered the P3 trial legitimate, they would have encouraged NWBO to file, but.........nothing. Even if MHRA buys it, FD
NWBO

Your Recent History

Delayed Upgrade Clock